Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cancer Cell. 2020 Sep 14;38(3):366-379.e8. doi: 10.1016/j.ccell.2020.06.003. Epub 2020 Jul 9.
Glioblastoma, the predominant adult malignant brain tumor, has been computationally classified into molecular subtypes whose functional relevance remains to be comprehensively established. Tumors from genetically engineered glioblastoma mouse models initiated by identical driver mutations in distinct cells of origin portray unique transcriptional profiles reflective of their respective lineage. Here, we identify corresponding transcriptional profiles in human glioblastoma and describe patient-derived xenografts with species-conserved subtype-discriminating functional properties. The oligodendrocyte lineage-associated glioblastoma subtype requires functional ERBB3 and harbors unique therapeutic sensitivities. These results highlight the importance of cell lineage in glioblastoma independent of driver mutations and provide a methodology for functional glioblastoma classification for future clinical investigations.
胶质母细胞瘤是成人中最主要的恶性脑肿瘤,已经通过计算方法将其分为分子亚型,但其功能相关性仍有待全面建立。由相同的驱动基因突变在不同起源细胞引发的基因工程胶质母细胞瘤小鼠模型的肿瘤表现出独特的转录谱,反映了其各自的谱系。在这里,我们在人类胶质母细胞瘤中识别出相应的转录谱,并描述了具有物种保守的亚型区分功能特性的患者来源异种移植物。与少突胶质细胞谱系相关的胶质母细胞瘤亚型需要功能性 ERBB3,并具有独特的治疗敏感性。这些结果强调了胶质母细胞瘤中细胞谱系的重要性,而与驱动突变无关,并为未来的临床研究提供了功能胶质母细胞瘤分类的方法。